Prediction of pertussis vaccine efficacy using a correlates of protection model
- 25 June 2008
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 26 (27-28), 3516-3521
- https://doi.org/10.1016/j.vaccine.2008.04.016
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A Framework for Assessing Immunological Correlates of Protection in Vaccine TrialsThe Journal of Infectious Diseases, 2007
- Use of statistical models for evaluating antibody response as a correlate of protection against varicellaStatistics in Medicine, 2002
- A search for serologic correlates of immunity to Bordetella pertussis cough illnessesVaccine, 1998
- Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussisVaccine, 1998
- Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccineThe Lancet, 1997
- A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis VaccineThe New England Journal of Medicine, 1996
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTSThe Lancet, 1988